1 results for "Marco Perruzza"
Showing 1–1 · 0.47 seconds · RSS
-
Journal Article
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena
Background: Idiopathic pulmonary fibrosis (IPF) is the most common idiopathic interstitial pneumonia and has a median survival after diagnosis of 2–5 years. Pirfenidone is the first approved antifibrotic drug for the treatment of IPF. Here we report the functional progress, side effects and…